Loading…
Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts
Background and purpose: While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lun...
Saved in:
Published in: | British journal of pharmacology 2008-10, Vol.155 (4), p.606-616 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 616 |
container_issue | 4 |
container_start_page | 606 |
container_title | British journal of pharmacology |
container_volume | 155 |
creator | Mair, K M MacLean, M R Morecroft, I Dempsie, Y Palmer, T M |
description | Background and purpose:
While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro.
Experimental approach:
PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts.
Key results:
ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT1B and 5‐HT2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression.
Conclusions and implications:
SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction.
British Journal of Pharmacology (2008) 155, 606–616; doi:10.1038/bjp.2008.310; published online 11 August 2008 |
doi_str_mv | 10.1038/bjp.2008.310 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2579673</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1574648561</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3319-d7263ef780f49d9a6e1ff89550c1effb6c7057486c0242b2aa68aa74d7c7f84a3</originalsourceid><addsrcrecordid>eNpVkc-OFCEQh4nRuOPqzbMhJt7skWpo_lxM3I06Jhs1Zj0TmgaHsQda6JnN3HwEn9EnkXXHVU-Qqi8fRf0QegxkCYTKF_1mWraEyCUFcgctgAnedFTCXbQghIgGQMoT9KCUDSG1Kbr76AQkVx1nZIEO79PejTjE2WVj55Biwb2br5yLeF473P38_mN1iedsYplSrtTzYw3OcHbWTXPKBZs44E_rhL-GaIqrOrwP-_S7XO_TbtymaPIB-9Dn1I-mzOUhuufNWNyj43mKPr95fXm-ai4-vH13_uqimSgF1Qyi5dR5IYlnalCGO_Beqq4jFpz3PbeCdIJJbknL2r41hktjBBuEFV4yQ0_RyxvvtOu3brAu1s-MesphWyfSyQT9fyeGtf6S9rrthOKCVsHToyCnbztXZr1JuxzrzLoFAUpxxSr05N9XbvV_Nl2BZ0fAFGtGXxdqQ7nlWiJBMpCVgxvuKozu8NdD9HXauqatr9PWNW199nFFQSr6C7bLn7o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217199694</pqid></control><display><type>article</type><title>Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts</title><source>Wiley</source><source>PubMed Central</source><creator>Mair, K M ; MacLean, M R ; Morecroft, I ; Dempsie, Y ; Palmer, T M</creator><creatorcontrib>Mair, K M ; MacLean, M R ; Morecroft, I ; Dempsie, Y ; Palmer, T M</creatorcontrib><description>Background and purpose:
While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro.
Experimental approach:
PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts.
Key results:
ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT1B and 5‐HT2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression.
Conclusions and implications:
SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction.
British Journal of Pharmacology (2008) 155, 606–616; doi:10.1038/bjp.2008.310; published online 11 August 2008</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/bjp.2008.310</identifier><identifier>PMID: 18695640</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>5‐HT ; Amides - pharmacology ; Animals ; Antihypertensive Agents - pharmacology ; Biological and medical sciences ; Cell Proliferation ; Cricetinae ; Cricetulus ; Extracellular Signal-Regulated MAP Kinases - metabolism ; fibroblast ; Fibroblasts - metabolism ; Humans ; Hypertension, Pulmonary - physiopathology ; Hypoxia - metabolism ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Pharmacology. Drug treatments ; Pneumology ; proliferation ; pulmonary arterial hypertension ; Pulmonary Artery - cytology ; Pulmonary Artery - metabolism ; Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases ; Pyridines - pharmacology ; Receptor, Serotonin, 5-HT1B - drug effects ; Receptor, Serotonin, 5-HT1B - metabolism ; Receptor, Serotonin, 5-HT2A - metabolism ; Research Papers ; Rho kinase ; rho-Associated Kinases - metabolism ; Serotonin Plasma Membrane Transport Proteins - metabolism ; Signal Transduction - physiology</subject><ispartof>British journal of pharmacology, 2008-10, Vol.155 (4), p.606-616</ispartof><rights>2008 British Pharmacological Society</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Oct 2008</rights><rights>Copyright 2008, Macmillan Publishing Group 2008 Macmillan Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579673/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579673/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20818418$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18695640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mair, K M</creatorcontrib><creatorcontrib>MacLean, M R</creatorcontrib><creatorcontrib>Morecroft, I</creatorcontrib><creatorcontrib>Dempsie, Y</creatorcontrib><creatorcontrib>Palmer, T M</creatorcontrib><title>Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Background and purpose:
While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro.
Experimental approach:
PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts.
Key results:
ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT1B and 5‐HT2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression.
Conclusions and implications:
SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction.
British Journal of Pharmacology (2008) 155, 606–616; doi:10.1038/bjp.2008.310; published online 11 August 2008</description><subject>5‐HT</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Proliferation</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>fibroblast</subject><subject>Fibroblasts - metabolism</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Hypoxia - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Pharmacology. Drug treatments</subject><subject>Pneumology</subject><subject>proliferation</subject><subject>pulmonary arterial hypertension</subject><subject>Pulmonary Artery - cytology</subject><subject>Pulmonary Artery - metabolism</subject><subject>Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases</subject><subject>Pyridines - pharmacology</subject><subject>Receptor, Serotonin, 5-HT1B - drug effects</subject><subject>Receptor, Serotonin, 5-HT1B - metabolism</subject><subject>Receptor, Serotonin, 5-HT2A - metabolism</subject><subject>Research Papers</subject><subject>Rho kinase</subject><subject>rho-Associated Kinases - metabolism</subject><subject>Serotonin Plasma Membrane Transport Proteins - metabolism</subject><subject>Signal Transduction - physiology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkc-OFCEQh4nRuOPqzbMhJt7skWpo_lxM3I06Jhs1Zj0TmgaHsQda6JnN3HwEn9EnkXXHVU-Qqi8fRf0QegxkCYTKF_1mWraEyCUFcgctgAnedFTCXbQghIgGQMoT9KCUDSG1Kbr76AQkVx1nZIEO79PejTjE2WVj55Biwb2br5yLeF473P38_mN1iedsYplSrtTzYw3OcHbWTXPKBZs44E_rhL-GaIqrOrwP-_S7XO_TbtymaPIB-9Dn1I-mzOUhuufNWNyj43mKPr95fXm-ai4-vH13_uqimSgF1Qyi5dR5IYlnalCGO_Beqq4jFpz3PbeCdIJJbknL2r41hktjBBuEFV4yQ0_RyxvvtOu3brAu1s-MesphWyfSyQT9fyeGtf6S9rrthOKCVsHToyCnbztXZr1JuxzrzLoFAUpxxSr05N9XbvV_Nl2BZ0fAFGtGXxdqQ7nlWiJBMpCVgxvuKozu8NdD9HXauqatr9PWNW199nFFQSr6C7bLn7o</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Mair, K M</creator><creator>MacLean, M R</creator><creator>Morecroft, I</creator><creator>Dempsie, Y</creator><creator>Palmer, T M</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>200810</creationdate><title>Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts</title><author>Mair, K M ; MacLean, M R ; Morecroft, I ; Dempsie, Y ; Palmer, T M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3319-d7263ef780f49d9a6e1ff89550c1effb6c7057486c0242b2aa68aa74d7c7f84a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>5‐HT</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Proliferation</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>fibroblast</topic><topic>Fibroblasts - metabolism</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Hypoxia - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Pharmacology. Drug treatments</topic><topic>Pneumology</topic><topic>proliferation</topic><topic>pulmonary arterial hypertension</topic><topic>Pulmonary Artery - cytology</topic><topic>Pulmonary Artery - metabolism</topic><topic>Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases</topic><topic>Pyridines - pharmacology</topic><topic>Receptor, Serotonin, 5-HT1B - drug effects</topic><topic>Receptor, Serotonin, 5-HT1B - metabolism</topic><topic>Receptor, Serotonin, 5-HT2A - metabolism</topic><topic>Research Papers</topic><topic>Rho kinase</topic><topic>rho-Associated Kinases - metabolism</topic><topic>Serotonin Plasma Membrane Transport Proteins - metabolism</topic><topic>Signal Transduction - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mair, K M</creatorcontrib><creatorcontrib>MacLean, M R</creatorcontrib><creatorcontrib>Morecroft, I</creatorcontrib><creatorcontrib>Dempsie, Y</creatorcontrib><creatorcontrib>Palmer, T M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mair, K M</au><au>MacLean, M R</au><au>Morecroft, I</au><au>Dempsie, Y</au><au>Palmer, T M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2008-10</date><risdate>2008</risdate><volume>155</volume><issue>4</issue><spage>606</spage><epage>616</epage><pages>606-616</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>Background and purpose:
While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro.
Experimental approach:
PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts.
Key results:
ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT1B and 5‐HT2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression.
Conclusions and implications:
SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction.
British Journal of Pharmacology (2008) 155, 606–616; doi:10.1038/bjp.2008.310; published online 11 August 2008</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18695640</pmid><doi>10.1038/bjp.2008.310</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2008-10, Vol.155 (4), p.606-616 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2579673 |
source | Wiley; PubMed Central |
subjects | 5‐HT Amides - pharmacology Animals Antihypertensive Agents - pharmacology Biological and medical sciences Cell Proliferation Cricetinae Cricetulus Extracellular Signal-Regulated MAP Kinases - metabolism fibroblast Fibroblasts - metabolism Humans Hypertension, Pulmonary - physiopathology Hypoxia - metabolism Medical sciences Mice Mice, Inbred C57BL Pharmacology. Drug treatments Pneumology proliferation pulmonary arterial hypertension Pulmonary Artery - cytology Pulmonary Artery - metabolism Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases Pyridines - pharmacology Receptor, Serotonin, 5-HT1B - drug effects Receptor, Serotonin, 5-HT1B - metabolism Receptor, Serotonin, 5-HT2A - metabolism Research Papers Rho kinase rho-Associated Kinases - metabolism Serotonin Plasma Membrane Transport Proteins - metabolism Signal Transduction - physiology |
title | Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A08%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20interactions%20between%20the%205%E2%80%90HT%20transporter,%205%E2%80%90HT1B%20receptors%20and%20Rho%20kinase%20in%20vivo%20and%20in%20pulmonary%20fibroblasts&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Mair,%20K%20M&rft.date=2008-10&rft.volume=155&rft.issue=4&rft.spage=606&rft.epage=616&rft.pages=606-616&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/bjp.2008.310&rft_dat=%3Cproquest_pubme%3E1574648561%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3319-d7263ef780f49d9a6e1ff89550c1effb6c7057486c0242b2aa68aa74d7c7f84a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217199694&rft_id=info:pmid/18695640&rfr_iscdi=true |